Summary of Significant Accounting Policies (Narrative) (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2012
Significant Accounting Policies [Line Items]
Receivable Balance	$ 6,449,691		$ 6,449,691		$ 5,373,023
Accounts receivable, allowance for doubtful accounts	903,961		903,961		991,990
Revenue from pharmaceutical clients	2,207,837	1,000,821	4,649,531	2,030,663
Bad debt expense			818,451	307,265
Amortization period of software development costs	5 years		5 years
Line of credit, expiration date			Mar. 07, 2015
Line of credit, fee for unused portion			0.25%	0.375%
Line of credit, minimum quick ratio			1.5
Line of credit, maximum borrowing capacity	2,000,000		2,000,000
Line of credit, borrowing base percentage of pharmaceutical accounts receivable	80.00%		80.00%
Line of credit, interest above prime rate			1.00%
Line of credit, interest charged			5.00%
Line of credit, amount drawn	1,000,000		1,000,000		1,000,000
Required minimum bank balance	4,000,000		4,000,000
Advertising costs	3,324	4,090	3,324	12,971
Uninsured foreign cash balance	6,972		6,972
Federal Insurance Coverage Reverted					250,000
Letter of Credit [Member]
Significant Accounting Policies [Line Items]
Line of credit, maximum borrowing capacity	500,000		500,000
Cost of Goods, Total [Member] | Supplier Concentration Risk [Member]
Significant Accounting Policies [Line Items]
Concentration risk percentage	93.00%	69.00%	92.00%	69.00%
University of Southern California [Member]
Significant Accounting Policies [Line Items]
Royalties expensed in cost of revenue	86,908	75,938	191,014	132,440
Roche Molecular Systems [Member]
Significant Accounting Policies [Line Items]
Royalties expensed in cost of revenue	84,362	80,418	174,507	143,887
Clinical [Member]
Significant Accounting Policies [Line Items]
Receivable Balance	2,360,808		2,360,808		2,549,665
Payment period from the date of invoice			45 days
ResponseDX [Member]
Significant Accounting Policies [Line Items]
Accounts receivable, allowance for doubtful accounts	903,961		903,961		991,990
Bad debt expense	$ 349,984	$ 51,340	$ 818,451	$ 307,265